Come and join us across the globe
Italo Linfante shares results from the Phase 1 Hemera-1 trial and propensity score analysis, testing carboxyhemoglobin oxygen (a bovine-derived therapy) in acute stroke revascularization. The early findings are positive, highlighting its potential as a new neuroprotective approach.
